• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症机制与夜间哮喘。

Inflammatory mechanisms and nocturnal asthma.

作者信息

Barnes P J

机构信息

Cardiothoracic Institute, Brompton Hospital, London, United Kingdom.

出版信息

Am J Med. 1988 Jul 29;85(1B):64-70. doi: 10.1016/0002-9343(88)90245-8.

DOI:10.1016/0002-9343(88)90245-8
PMID:3041827
Abstract

The results of recent research strongly suggest that airway inflammation, which may increase at night as a result of circadian troughs in blood epinephrine and cortisol concentrations, underlies the bronchial hyperresponsiveness that is almost certainly a major contributor to the pathogenesis of nocturnal asthma. This article reviews what is known about the nature and complex interactions of the inflammatory cells and mediators that may be involved in asthma, with particular emphasis on nocturnal asthma. The roles of platelet-activating factor antagonists, corticosteroids, and theophylline in suppressing this response also are discussed.

摘要

近期研究结果有力地表明,气道炎症可能因血液中肾上腺素和皮质醇浓度的昼夜波动在夜间加剧,它是支气管高反应性的基础,而支气管高反应性几乎肯定是夜间哮喘发病机制的主要促成因素。本文综述了关于可能参与哮喘的炎症细胞和介质的性质及复杂相互作用的已知情况,尤其着重于夜间哮喘。还讨论了血小板活化因子拮抗剂、皮质类固醇和茶碱在抑制这种反应中的作用。

相似文献

1
Inflammatory mechanisms and nocturnal asthma.炎症机制与夜间哮喘。
Am J Med. 1988 Jul 29;85(1B):64-70. doi: 10.1016/0002-9343(88)90245-8.
2
Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.支气管哮喘发病机制中的超敏反应介质和炎症细胞
Eur J Respir Dis Suppl. 1983;129:1-44.
3
[Inflammatory aspects in bronchial asthma].
Kokyu To Junkan. 1991 Sep;39(9):845-9.
4
Mediators and asthma.
Br J Hosp Med. 1985 Dec;34(6):339-44.
5
Mechanisms of inflammation in the asthmatic patient.哮喘患者的炎症机制。
Allergy Proc. 1993 Jan-Feb;14(1):5-8. doi: 10.2500/108854193778816752.
6
Mechanisms of inflammation and their therapeutic implications in the asthmatic patient.炎症机制及其在哮喘患者中的治疗意义。
Ann Allergy. 1992 Sep;69(3):261-6.
7
The mast cell and theophylline in asthma.
Am J Med. 1985 Dec 20;79(6A):22-5. doi: 10.1016/0002-9343(85)90083-x.
8
[Cysteinyl-leukotrienes: important mediators in asthma].[半胱氨酰白三烯:哮喘中的重要介质]
Rev Med Liege. 1997 Sep;52(9):598-602.
9
Role of inflammatory mediators in asthma.炎症介质在哮喘中的作用。
Br Med Bull. 1992 Jan;48(1):135-48. doi: 10.1093/oxfordjournals.bmb.a072530.
10
Evidence favouring PAF rather than leukotrienes in the pathogenesis of asthma.
Pharmacol Res Commun. 1986 Aug;18 Suppl:217-37. doi: 10.1016/0031-6989(86)90055-x.

引用本文的文献

1
Effects of physical exercise training on nocturnal symptoms in asthma: Systematic review.运动训练对哮喘夜间症状的影响:系统评价。
PLoS One. 2018 Oct 22;13(10):e0204953. doi: 10.1371/journal.pone.0204953. eCollection 2018.
2
Effects of adenosine on guinea pig pulmonary eosinophils.腺苷对豚鼠肺嗜酸性粒细胞的影响。
Inflammation. 1996 Feb;20(1):11-21. doi: 10.1007/BF01487741.
3
Potassium channels and airway function: new therapeutic prospects.钾通道与气道功能:新的治疗前景。
Thorax. 1990 Mar;45(3):213-8. doi: 10.1136/thx.45.3.213.
4
Nocturnal asthma.夜间哮喘
BMJ. 1992 Apr 18;304(6833):998-9. doi: 10.1136/bmj.304.6833.998.